Efficacy and safety of Elbasvir/Grazoprevir in women infected with hepatitis C virus genotype 1 or 4 and co-administered oral contraceptives or hormone replacement therapy Hezode, C., Kwo, P., Sperl, J., Dore, G., Hwang, P., Long, J., Talwani, R., Robertson, M., Haber, B. ELSEVIER SCIENCE BV. 2018: S264–S265

View details for Web of Science ID 000461068601134